Review decision date: June 2011
This guideline should not be updated at this time. For further information, please refer to the surveillance review decision.
This guideline will shortly be checked to see if it needs updating, please register as a stakeholder to be informed about the decision.
Next review date: May 2016
NICE has produced two guidelines on drug misuse – ‘Drug misuse: psychosocial interventions’ (NICE guideline CG51) and ‘Drug misuse: opioid detoxification’ (NICE guideline CG52). They cover:
- the support and treatment people can expect to be offered if they have a problem with or are dependent on opioids, stimulants or cannabis
- how families and carers may be able to support a person with a drug problem and get help for themselves.
NICE guideline CG51 makes recommendations for the use of psychosocial interventions in the treatment of people who misuse opioids, stimulants and cannabis in the healthcare and criminal justice systems.
NICE has produced joint information for the public that covers both guidelines, as well as tools to help organisations implement this guidance – these have been integrated with tools for other NICE guidance on drug misuse.